Showing posts with label caspases. Show all posts
Showing posts with label caspases. Show all posts

Monday, 17 March 2025

Role of Caspase-12 in Hepatocyte Apoptosis Induced by Carbon Tetrachloride in Mice | Chapter 13 | Medical Science: Trends and Innovations Vol. 10

Toxic liver damage can lead to acute liver failure, hepatic fibrosis, and even carcinogenesis. This study aimed to explore the role of caspase-12 and its downstream targets in hepatocyte apoptosis induced by carbon tetrachloride (CCl4). To determine the role of caspase-12, caspase-12 knockout mice were used. Wild-type and caspase-12 knockout mice received a single intraperitoneal injection of either CCl4 (300 μl/kg BW) or vehicle (corn oil). The animals were sacrificed 24 hours after treatment, and blood samples were collected to assess liver function through alanine aminotransferase activity. Liver samples were analyzed for reactive oxygen species (ROS) levels using plasma malondialdehyde as a biomarker, hepatocyte apoptosis via TUNEL assay and morphological analysis, and cytochrome C release and caspase activation through western blotting.

In wild-type mice, low-dose CCl4 administration caused hepatocyte apoptosis and acute liver injury, accompanied by increased ROS production and endoplasmic reticulum (ER) stress in the liver. These events triggered the activation of caspases-12, -9, and -3, along with the release of small amounts of cytochrome C. However, in CCl4-treated caspase-12 knockout mice, the activation of caspases-9 and -3 was significantly reduced, while cytochrome C release remained unaffected. Compared to wild-type mice, CCl4-induced apoptosis and liver damage were substantially attenuated in caspase-12 knockout mice (p < 0.05). Notably, the active form of caspase-8 was not detected in either wild-type or knockout mice. Additionally, there was no significant difference in ROS formation between the two groups following CCl4 treatment.

These findings demonstrate that caspase-12 plays a critical role in CCl4-induced hepatic apoptosis by directly or indirectly activating effector caspase-3 downstream, with partial involvement of caspase-9 activation. In conclusion, prolonged exposure to even low levels of CCl4 could cause liver pathology in humans, warranting further clinical and animal studies to investigate the long-term consequences of minimal exposure.

 

Author (s) Details

Hua Liu
Division of Pediatric Gastroenterology, Department of Pediatrics, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.

 

Madison Nicole Burton
University of Mississippi Medical Center, Jackson, MS 39216, USA.

 

Neha Dhaliwal
William Carey University, 710 William Carey Pkwy, Hattiesburg, MS 39401, USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/msti/v10/4801

Thursday, 7 July 2022

Antioxidant Levels and Inhibition of Cancer Cell Proliferation In-vitro by Extracts from Peltophorum pterocarpum Collected in Vietnam | Chapter 6 | Current Practice in Medical Science Vol. 4

A common ornamental and deciduous tree, Peltophorum pterocarpum is endemic to tropical South-Eastern Asian nations. Examining the effects of 70% ethanolic extracts of P. pterocarpum leaves (LPP) and stem bark on low-density lipoprotein oxidation and cytotoxic activity against cancer cell lines is the goal of this study (SPP). The outcomes demonstrated that both LPP and SPP, in a dose-dependent way, reduced the production of thiobarbituric acid reactive compounds as well as Cu2+-mediated low-density lipoprotein. Additionally, MIA PACA2, A549, KG, HL-60, and CRF-SBA were significantly toxic to by SPP, with IC50 values ranging from 118.5 to 255.0 g/mL. KG, HL-60, and CCRF-SBA were all susceptible to the cytotoxic effects of LPP, with IC50 values ranging from 146.0 to 228.1 g/mL. In HL-60 and CCRF-SBA cells, SPP also caused cytotoxicity by activating the apoptotic pathway. These results showed that SPP could prevent the onset and progression of atherosclerosis and leukaemia in people.


Author(s) Details:

Dao Cuong To,
Phenikaa University Nano Institute (PHENA), Phenikaa University, Yen Nghia, Ha Dong district, Hanoi 12116, Vietnam and Phenikaa Research and Technology Institute (PRATI), A&A Green Phoenix Group JSC, 167 Hoang Ngan, Cau Giay District, Hanoi 11313, Vietnam.

Phi Hung Nguyen,
Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet street, Cau Giay District, Hanoi 122100, Vietnam.

Kim Thuong Pham Van,
School of Medicine and Pharmacy, The University of Danang, Hoa Quy, Ngu Hanh Son District, Danang city 550000, Vietnam.

Loi Huynh,
School of Medicine and Pharmacy, The University of Danang, Hoa Quy, Ngu Hanh Son District, Danang city 550000, Vietnam.

Manh Hung Tran,
School of Medicine and Pharmacy, The University of Danang, Hoa Quy, Ngu Hanh Son District, Danang city 550000, Vietnam.